Cargando…

Hypermethylation and Expression Silencing of PDCD4 Gene in Hepatocellular Carcinoma: A Consort Study

Programmed cell death 4 (PDCD4) is a novel tumor suppressor, which is involved in the initiation and progression of cancers. However, the role of PDCD4 in hepatocellular carcinoma (HCC) has not been reported. The aim of this study was to investigate the molecular mechanism and clinical significance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Xianglian, Cheng, Xifang, Gong, Meixia, Chen, Xiaojun, Yin, Fang, Lai, Kailan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753909/ https://www.ncbi.nlm.nih.gov/pubmed/26871813 http://dx.doi.org/10.1097/MD.0000000000002729

Ejemplares similares

Fibulin-1 Is Downregulated Through Promoter Hypermethylation in Colorectal Cancer: A Consort Study
por: Xu, Zhiying, et al.
Publicado: (2015)

Association between SOCS3 hypermethylation and HBV-related hepatocellular carcinoma and effect of sex and age: A meta-analysis
por: Zheng, Hairu, et al.
Publicado: (2021)

Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis
por: He, Bosheng, et al.
Publicado: (2017)

The association between polymorphisms in the PDCD1 gene and the risk of cancer: A PRISMA-compliant meta-analysis
por: Zhang, Jie, et al.
Publicado: (2016)

Prognostic significance of serum procalcitonin in patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization: A retrospective analysis of 509 cases
por: Shen, Hujia, et al.
Publicado: (2017)

Significant Association Between Adiponutrin and Hepatocellular Carcinoma Risk
por: Li, Hong-Guang, et al.
Publicado: (2015)

Dosimetric comparison between intensity-modulated radiotherapy and volumetric-modulated arc therapy in patients of left-sided breast cancer treated with modified radical mastectomy: CONSORT
por: Wang, Rui, et al.
Publicado: (2022)

A comprehensive investigation on pan-cancer impacts of constitutive centromere associated network gene family by integrating multi-omics data: A CONSORT-compliant article
por: Su, Huimei, et al.
Publicado: (2022)

Promoter hypermethylation of Wnt inhibitory factor-1 in patients with lung cancer: A systematic meta-analysis
por: Zheng, Yu, et al.
Publicado: (2016)

Impact of intraoperative allogenic and autologous transfusion on immune function and prognosis in patients with hepatocellular carcinoma
por: Gong, Youwei, et al.
Publicado: (2020)

CONSORT: Sam68 Is Directly Regulated by MiR-204 and Promotes the Self-Renewal Potential of Breast Cancer Cells by Activating the Wnt/Beta-Catenin Signaling Pathway
por: Wang, Lan, et al.
Publicado: (2015)

Ketorolac plus Lidocaine vs Lidocaine for pain relief following core needle soft tissue biopsy: A CONSORT-compliant double-blind randomized controlled study
por: Chobpenthai, Thanapon, et al.
Publicado: (2021)

Chemoembolization for hepatocellular carcinoma fed by right internal thoracic artery
por: Shen, Tao, et al.
Publicado: (2017)

Promoter hypermethylation of MGMT gene may contribute to the pathogenesis of gastric cancer: A PRISMA-compliant meta-analysis
por: Zhang, Zongxin, et al.
Publicado: (2017)

Clinical significance of down-regulated HINT2 in hepatocellular carcinoma
por: Zhou, Dong-Kai, et al.
Publicado: (2019)

Statin-Based Palliative Therapy for Hepatocellular Carcinoma
por: Shao, Joni Yu-Hsuan, et al.
Publicado: (2015)

Common Variants of the Prostaglandin-Endoperoxide Synthase 2 Gene and Hepatocellular Carcinoma Susceptibility
por: Li, Hong-guang, et al.
Publicado: (2015)

Efficacy and Safety of Intensity-Modulated Radiotherapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2016)

Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma: A Review
por: Bu, Fan, et al.
Publicado: (2022)

Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma
por: Fu, Changbo, et al.
Publicado: (2019)

Oxeiptosis core genes and their multi-omics analysis in hepatocellular carcinoma
por: Lin, Sen, et al.
Publicado: (2023)

Intelectin-1 is a novel prognostic biomarker for hepatocellular carcinoma
por: Li, Jiang, et al.
Publicado: (2023)

Clinicopathological and prognostic value of preoperative lymphocyte to monocyte ratio for hepatocellular carcinoma following curative resection: A meta-analysis including 4,092 patients
por: Lin, Shuwen, et al.
Publicado: (2021)

Efficacy and safety of transarterial chemoembolization plus lenvatinib in the treatment of advanced hepatocellular carcinoma: A meta-analysis
por: Li, Dailong, et al.
Publicado: (2023)

SOCS3 Genetic Polymorphism Is Associated With Clinical Features and Prognosis of Hepatocellular Carcinoma Patients Receiving Hepatectomy
por: Jiang, Bei-ge, et al.
Publicado: (2015)

Statins improve outcomes of nonsurgical curative treatments in hepatocellular carcinoma patients
por: Wu, Li-Li, et al.
Publicado: (2016)

Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma
por: Zhang, Ying, et al.
Publicado: (2017)

Higher neutrophil-lymphocyte ratio is associated with better prognosis of hepatocellular carcinoma
por: Li, Sheng-chao, et al.
Publicado: (2020)

Prognostic value of sarcopenic visceral obesity in hepatocellular carcinoma treated with TACE
por: Li, Yuxuan, et al.
Publicado: (2023)

High expression of HILPDA is an adverse prognostic prognostic factor in hepatocellular carcinoma
por: Wang, Xiao, et al.
Publicado: (2023)

Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection
por: Cai, Xiao-Yan, et al.
Publicado: (2016)

Serum SALL4 as a predictive biomarker for the prognosis of patients with hepatocellular carcinoma who underwent nonsurgical treatment
por: Chen, Zhixian, et al.
Publicado: (2022)

Hepatic Angiomyolipoma Mimicking Hepatocellular Carcinoma: Magnetic Resonance Imaging and Clinical Pathological Characteristics in 9 Cases
por: Wang, Chun-Ping, et al.
Publicado: (2014)

The Silencing of RECK Gene is Associated with Promoter Hypermethylation and Poor Survival in Hepatocellular Carcinoma
por: Zhang, Changsong, et al.
Publicado: (2012)

Radiofrequency Ablation of the Main Lesion of Hepatocellular Carcinoma and Bile Duct Tumor Thrombus as a Radical Therapeutic Alternative: Two Case Reports
por: Gao, Jun, et al.
Publicado: (2015)

Ectopic hepatocellular carcinoma manifesting multiple abdominal masses: A case report
por: Jin, RenAn, et al.
Publicado: (2017)

Prognostic significance of glypican-3 expression in hepatocellular carcinoma: A meta-analysis
por: Liu, Hong, et al.
Publicado: (2018)

Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib: Three case reports
por: Tomonari, Tetsu, et al.
Publicado: (2020)

Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis
por: Sun, Quanquan, et al.
Publicado: (2020)

Development and validation of a robust immune-related risk signature for hepatocellular carcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_00fnhiirpnf1tgbpm9c06ghp1a